Literature DB >> 16782560

Pulmonary manifestations in antiphospholipid syndrome.

Ljudmila Stojanovich1.   

Abstract

Pulmonary manifestations in antiphospholipid syndrome (APS) are relatively rare compared to other clinical signs of this disease. However, pulmonary microthrombosis is among the most frequent arterial complications of APS. Timely diagnosis of pulmonary manifestations is required due both to their severity and to the high mortality rate. The spectrum of pulmonary disorders in patients with antiphospholipid antibodies is sometimes referred to as the "antiphospholipid lung syndrome", and includes thromboembolism of lung arteries, pulmonary hypertension, adult respiratory distress syndrome, intra-alveolar hemorrhages, postpartum syndrome, and others. Timely diagnosis and correct therapy, as well as good patient-doctor collaboration, can result in stabilization of the patient's condition.

Entities:  

Mesh:

Year:  2006        PMID: 16782560     DOI: 10.1016/j.autrev.2006.02.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

Review 1.  Clinical and laboratory features of the catastrophic antiphospholipid syndrome.

Authors:  Ljudmila Stojanovich; Dragomir Marisavljevic; Jozef Rovensky; Aleksandra Djokovich; Darina Kozáková; Nikola Milinic
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 2.  Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?

Authors:  Rukma Parthvi; Rutuja R Sikachi; Abhinav Agrawal; Ajay Adial; Abhinav Vulisha; Sameer Khanijo; Arunabh Talwar
Journal:  Intractable Rare Dis Res       Date:  2017-08

3.  Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients.

Authors:  Rossana Mejía-Romero; Mario García-Carrasco; Claudio Galarza-Maldonado; Pedro Santos; Claudia Mendoza-Pinto; Ricardo O Escárcega; Salvador Salinas-Saldivar; Elena Soto-Vega; Aurelio López-Colombo; Ricard Cervera
Journal:  Clin Rheumatol       Date:  2007-12-22       Impact factor: 2.980

4.  Chronic catastrophic-like antiphospholipid syndrome: a “smoldering” variant?

Authors:  Daniel Athanazio; Maria Cristina Rocha; Túlio Geraldo de Souza e Souza; Natália Oliveira e Silva; Sérgio Jezler; Mittermayer Barreto Santiago
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

Review 5.  Cell damage and autoimmunity: a critical appraisal.

Authors:  Ian R Mackay; Natasha V Leskovsek; Noel R Rose
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

6.  Platelets in pulmonary hypertension: a causative role or a simple association?

Authors:  Keyhan Sayadpour Zanjani
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

7.  The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians.

Authors:  Juan-Sebastian Franco; Nicolás Molano-González; Monica Rodríguez-Jiménez; Yeny Acosta-Ampudia; Rubén D Mantilla; Jenny Amaya-Amaya; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

8.  Primary antiphospholipid syndrome associated Liebman-Sachs endocarditis leading to diffuse alveolar hemorrhage: A case report.

Authors:  Ryan Hyde; Martin Runnstrom; Austin Anderson; Leonard Riley; Ali Ataya
Journal:  Respir Med Case Rep       Date:  2018-08-24

9.  A 35-year-old man with dyspnea and hemoptysis.

Authors:  Ilad Alavi Darazam; Farid Azizi; Katayoon Najafizadeh; Davood Mansouri
Journal:  Tanaffos       Date:  2012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.